You must agree to the terms to view this video

By registering or choosing to view each Webcast or download podcasts, you agree to your contact information/data being shared with the presenter(s) or their companies who may pay to support your opportunity to view, hear, or download this event, notwithstanding your original intentions to opt-in or opt-out of communications from the event producer, this Web site producer, or other 3rd parties. Those earlier intentions will not be changed or affected by your acceptance of this notice.

Earlier this month, GW Pharmaceuticals reshaped the way many people view cannabis when the company reported positive Stage 3 Clinical data for its Epidiolex product. For thousands of years, people all over the world used cannabis for a medicine. During this topic, Michael Berger, President of, will discuss how cannabis could shake up the pharmaceutical industry through the development of less harmful treatments for various illnesses.
Michael Berger
Duration: 22:55